Host-directed Therapies for Drug-resistant Infections
Host-directed therapies (HDTs) are a novel approach to fighting drug-resistant infections. They involve the use of drugs and other interventions to target and modulate the host’s own physiological processes, rather than directly attacking the pathogen. By targeting the host, HDT treatments can potentially reduce the amount of antibiotics needed, or even provide a viable alternative to antibiotics. HDTs have the potential to revolutionize the treatment of drug-resistant infections and are a promising area of research for the development of new treatments. HDTs work by targeting specific pathways in the host to modulate the immune response or to disrupt microbial processes. They can be used in combination with conventional antibiotic treatments or as stand-alone treatments, depending on the nature of the infection. HDTs have the potential to reduce antibiotic resistance, reduce the need for antibiotics and revolutionize the treatment of drug-resistant infections.
← Journal of Drug Resistant Pathogen Research